Note 10 - Share-based Compensation - Schedule of Allocated Expense (Details) - USD ($) |
3 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Share-based compensation expense | $ 2,674,105 | $ 3,406,949 |
| FC2 Female Condom [Member] | Discontinued Operations, Disposed of by Sale [Member] | ||
| Share-based compensation expense, discontinued operations | (10,049) | 523,146 |
| Selling, General and Administrative Expenses [Member] | ||
| Share-based compensation expense | 2,004,716 | 2,400,424 |
| Research and Development Expense [Member] | ||
| Share-based compensation expense | $ 679,438 | $ 483,379 |
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (benefit) for award under share-based payment arrangement. Excludes amount capitalized. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|